CDK4 and adenocarcinoma: We utilized MMTV-rtTA/tetO-HER2 transgenic mice, which develop spontaneously arising, cyclin D1 and Rb-expressing, CDK4/6i–sensitive adenocarcinomas within developmentally normal, mature mammary glands (25, 33).